Illumina, Inc. (ILMN)财务
NASDAQ · Healthcare · Medical - Diagnostics & Research · 员工8,600人 · CEO Jacob Thaysen
- 股价
- $235.99 -18.64%
- 市值
- $356亿
- 企业价值
- $366亿
- 最近财报
- Q3 '26 2026-10-30提交
- 下次财报
- 2027-02-04
营收(TTM)$45.4亿+5.9% 对比去年同期最近4个季度;柱状图=各季度
营业利润率(TTM)22.4%+2.8 百分点 对比去年同期营业利润 $10.2亿
净利润(TTM)$8.95亿+27.3% 对比去年同期税后,含营业外收益
自由现金流(TTM)$10.6亿+5.0% 对比去年同期资本支出 $1.73亿
稀释EPS(TTM)$5.82+30.5% 对比去年同期最近4个季度之和
净现金-$8.91亿+31.4% 对比去年同期现金 + 短期投资 - 债务
估值与关键数据
- 市值
- $356亿 EV $366亿
- 营收
- $45.4亿 过去12个月
- 营收增速
- +7% FY2026年一致预期
- 净利润率
- 19.7% 净利润 / 营收,TTM
- P/E
- 40.1× 预期 43.7×(FY2026)
- P/S
- 7.9× 股价 / 营收,TTM
- EV / EBITDA
- 26.4× TTM
- 自由现金流
- $10.6亿 过去12个月
- 净利润
- $8.95亿 过去12个月
- 营收预期
- $46.3亿 FY2026年一致预期
- 盈利
- 2027-02-04
- 股息
- – 无股息
核心要点
根据披露数据计算,每条结论都附有其依据的数字。
- 营收增长平稳:同比4.2%Q3 '26营收$11.3亿,此前四个季度的平均值为5.0%。
- 营业利润率22.4%(TTM),较去年同期+2.8 百分点营收增长5.9%,营业利润增长21.1%。
- 资本支出占营收的3.8%(去年为2.7%)最近4个季度投入$1.73亿(同比+50.4%)。自由现金流$10.6亿,相当于净利润的118.1%。
- 股东回报$5100万 = 自由现金流的4.8%回购$5100万(去年为$7.17亿),股息$0,股权激励$0(TTM)。
- 稀释股数一年内增加0.0%Q3 '26稀释股数1.54亿,一年前为1.54亿。
- 净债务 $8.91亿现金 + 短期投资 $13.4亿,含租赁债务 $22.3亿;一年前净债务 $13亿。
上一季度:Q3 '26
截至2026-09-27的季度。与去年同期及财报发布前的分析师一致预期对比。
本季度与去年同期
| Q3 '26 | 去年同期 | 变化 | |
|---|---|---|---|
| 营收 | $11.3亿 | $10.8亿 | +4.2% |
| 毛利率 | 73.5% | 67.6% | +5.9 百分点 |
| 营业利润 | $3.05亿 | $2.31亿 | +32.0% |
| 营业利润率 | 27.0% | 21.3% | +5.7 百分点 |
| 净利润 | $2.2亿 | $1.5亿 | +46.7% |
| 稀释EPS | $1.43 | $0.97 | +47.4% |
| 经营现金流 | $4.19亿 | $2.84亿 | +47.5% |
| 资本支出 | $4100万 | $2400万 | +70.8% |
| 自由现金流 | $3.78亿 | $2.6亿 | +45.4% |
| R&D | $2.44亿 | $2.28亿 | +7.0% |
| 股权激励费用 | $0 | $7000万 | -100.0% |
营收
收入从何而来,按业务线和地区逐季展示。
营收、营业利润与增速
季度按业务线划分的营收
堆叠,季度| 分部 | Q3 '26 | 同比 | 占比 | TTM | TTM同比 | 12个季度 |
|---|---|---|---|---|---|---|
| Sequencing | $10.2亿 | +2.0% | 90.4% | $41.4亿 | – | |
| Microarray | $1.08亿 | +30.1% | 9.6% | $4.03亿 | – |
按地区划分的营收
占总额比例| 分部 | Q3 '26 | 同比 | 占比 | TTM | TTM同比 | 12个季度 |
|---|---|---|---|---|---|---|
| Americas | – | – | – | – | – | |
| EMEA | $3.47亿 | +12.3% | 70.5% | $14.2亿 | +14.9% | |
| Asia Pacific | $8600万 | -22.5% | 17.5% | $3.74亿 | -12.2% | |
| CHINA | $5900万 | +13.5% | 12.0% | $2.23亿 | -16.5% |
分部利润
取自每份10-Q / 10-K分部附注的各披露分部营业利润(多数数据源缺少的利润拆分)。
Q3 '26分部
| 分部 | 营收 | 同比 | 营业利润 | 同比 | 利润率 | 去年同期利润率 | TTM营业利润 |
|---|---|---|---|---|---|---|---|
| Core Illumina | – | – | $3.05亿 | – | – | – | – |
| GRAIL Inc. | – | – | – | – | – | – | – |
各分部营业利润
季度各分部营业利润率
季度利润率与成本结构
每一单位营收在各层级还剩多少,成本又花在哪里。
利润率
季度成本占营收比例
季度现金流与资本配置
创造了多少现金,用在何处,又有多少回到股东手中。
经营现金流、资本支出、自由现金流
季度现金用途与经营现金流
财年最近4个季度
现金流量表- 经营现金流
- $12.3亿
- 资本支出
- -$1.73亿
- 股票回购
- -$5100万
- 股息
- $0
- 收购
- $0
- 债务净发行
- -$2.08亿
- 股权激励费用
- $0
- 自由现金流
- $10.6亿
- 股东回报 / FCF
- 4.8%
股数与EPS
季度,稀释资产负债表
各季度末的流动性、投资和债务。
现金、投资与债务
季度末估值与回报
当前估值倍数与公司自身过去五个财年对比;分析师目标价与评级。
估值倍数与回报
TTM与过去5个财年| 当前 | 5年均值 | 当前处于5年区间的位置 | |
|---|---|---|---|
| P/E(TTM) | 40.1× | 48.7× 5年中的2年 | 24.5× – 72.9× |
| EV / EBITDA | 26.4× | 31.3× 5年中的2年 | 15.1× – 47.5× |
| EV / 营收 | 8.1× | 7.0× | 5.0× – 12.6× |
| 股价 / FCF | 33.7× | 116.8× | 22.4× – 291.0× |
| 股价 / 净资产 | 11.3× | 6.0× | 3.7× – 8.9× |
| FCF收益率 | 3.0% | 2.0% | 0.3% – 4.5% |
| 投入资本回报率 | 15.0% | -11.1% | -38.7% – 12.0% |
| 净资产收益率 | 31.5% | -20.0% | -66.7% – 31.2% |
分析师
一致目标价 $252.73 (+7.1%)
区间 $155.00 – $305.00 · 评级 Buy
强烈买入1
买入26
持有17
卖出6
强烈卖出0
展望
分析师对未来财年的一致预期,以及按当前股价意味着什么。
一致预期
| 财年 | 营收 | 增速 | EPS | 增速 | 按当前股价的P/E | 分析师(EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $46.3亿 | +6.7% | $5.40 | -0.9% | 43.7× | 11 |
| FY2027 | $49.4亿 | +6.6% | $6.14 | +13.6% | 38.5× | 12 |
| FY2028 | $53亿 | +7.4% | $7.03 | +14.5% | 33.6× | 7 |
| FY2029 | $57.9亿 | +9.3% | $8.03 | +14.2% | 29.4× | 4 |
| FY2030 | $61.4亿 | +6.0% | $8.95 | +11.5% | 26.4× | 2 |
财务报表
利润表、资产负债表和现金流量表的每一项,含12个季度和10个财年,以金额、占营收比例或增速展示。
全部披露项目
Illumina, Inc.在近期10-Q / 10-K文件中标记的全部251项数据,附SEC官方标签和定义,包括附注(租赁、税务、回购、员工等)。
| 项目(SEC标签) | 最近季度 | 去年同期 | 同比 | 最近财年 | 上一财年 | 同比 |
|---|---|---|---|---|---|---|
| Accounts Payable, Current | $2.41亿 | $2.18亿 | +10.6% | $2.4亿 | $2.21亿 | +8.6% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $7.38亿 | $7.29亿 | +1.2% | $8.54亿 | $7.35亿 | +16.2% |
| Accounts Receivable, Allowance for Credit Loss, Current | $800万 | $900万 | -11.1% | $700万 | $900万 | -22.2% |
| Accounts Receivable, before Allowance for Credit Loss, Current | $7.46亿 | $7.38亿 | +1.1% | $8.61亿 | $7.44亿 | +15.7% |
| Accrued Liabilities, Current | $9.15亿 | $7.46亿 | +22.7% | $8.46亿 | $8.27亿 | +2.3% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $13.6亿2025-12-28 | $12.5亿 | +8.7% | $13.6亿 | $12.5亿 | +8.7% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $800万 | -$1200万 | +166.7% | -$1000万 | $2200万 | -145.5% |
| Additional Paid in Capital | $80.3亿 | $77.6亿 | +3.5% | $78.2亿 | $75.3亿 | +3.9% |
| Advertising Expense | – | – | – | $3700万 | $3700万 | 0.0% |
| Amortization of Intangible Assets | $2000万 | $1700万 | +17.6% | $6700万 | $1.3亿 | -48.5% |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 0 | 200万 | -100.0% | 200万 | 400万 | -50.0% |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $7500万 | $7000万 | +7.1% | $2.75亿 | $3.18亿 | -13.5% |
| Assets | $68.1亿 | $61.8亿 | +10.3% | $66.4亿 | $63亿 | +5.4% |
| Assets, Current | $30.4亿 | $28亿 | +8.5% | $32.9亿 | $27.5亿 | +19.8% |
| Assets, Fair Value Disclosure | $11.3亿 | – | – | $15亿 | $11.1亿 | +34.9% |
| Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | -$1100万 | $300万 | -466.7% | -$1800万 | -$3.15亿 | +94.3% |
| Business Combination, Contingent Consideration, Liability | $3600万 | – | – | $5400万 | $7300万 | -26.0% |
| Business Combination, Contingent Consideration, Liability, Current | $3800万2026-06-28 | – | – | $100万2022-01-02 | $0 | – |
| Capital Expenditures Incurred but Not yet Paid | – | – | – | $2200万 | $400万 | +450.0% |
| Cash and Cash Equivalents, Fair Value Disclosure | $9.69亿 | – | – | $11.7亿 | $9.31亿 | +26.0% |
| Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months | $100万 | $700万 | -85.7% | -$1500万 | $2700万 | -155.6% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $12.9亿 | $10.5亿 | +22.8% | $14.2亿 | $11.3亿 | +25.8% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $2.49亿 | $1.16亿 | +114.7% | $2.91亿 | $7900万 | +268.4% |
| Common Stock, Par or Stated Value Per Share | $0.012025-12-28 | $0.01 | 0.0% | $0.01 | $0.01 | 0.0% |
| Common Stock, Shares Authorized | 3.2亿2025-12-28 | 3.2亿 | 0.0% | 3.2亿 | 3.2亿 | 0.0% |
| Common Stock, Shares, Issued | 2.01亿2025-12-28 | 2亿 | +0.5% | 2.01亿 | 2亿 | +0.5% |
| Common Stock, Shares, Outstanding | 1.53亿2025-12-28 | 1.59亿 | -3.8% | 1.53亿 | 1.59亿 | -3.8% |
| Common Stock, Value, Issued | $200万 | $200万 | 0.0% | $200万 | $200万 | 0.0% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $2.2亿 | $1.59亿 | +38.4% | $8.18亿 | -$12亿 | +168.2% |
| Contract with Customer, Asset, after Allowance for Credit Loss | $2000万 | $2200万 | -9.1% | $2100万 | $1600万 | +31.3% |
| Contract with Customer, Liability | $3.19亿 | $3.07亿 | +3.9% | $3.46亿 | $3.27亿 | +5.8% |
| Contract with Customer, Liability, Current | $2.5亿 | $2.34亿 | +6.8% | $2.7亿 | $2.6亿 | +3.8% |
| Contract with Customer, Liability, Revenue Recognized | $4700万 | $4700万 | 0.0% | $2.44亿 | – | – |
| Cost of Revenue | $2.99亿 | $3.51亿 | -14.8% | $14.7亿 | $15.1亿 | -2.5% |
| Cost, Amortization | $1800万 | $1600万 | +12.5% | $6600万 | $1.27亿 | -48.0% |
| Current Federal Tax Expense (Benefit) | – | – | – | $0 | $600万 | -100.0% |
| Current Foreign Tax Expense (Benefit) | – | – | – | $1.04亿 | $1.37亿 | -24.1% |
| Current Income Tax Expense (Benefit) | – | – | – | $1.17亿 | $1.61亿 | -27.3% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $1300万 | $1800万 | -27.8% |
| Deferred Compensation Cash-based Arrangements, Liability, Current and Noncurrent | $7200万2025-12-28 | $6500万 | +10.8% | $7200万 | $6500万 | +10.8% |
| Deferred Compensation Liability, Current and Noncurrent | $6900万 | – | – | $7200万 | $6500万 | +10.8% |
| Deferred Compensation Plan Assets | $8400万 | – | – | $7900万 | $7000万 | +12.9% |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | $1.06亿 | -$5900万 | +279.7% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | -$600万 | -$200万 | -200.0% |
| Deferred Income Tax Assets, Net | $4.54亿 | $4.9亿 | -7.3% | $4.54亿 | $5.67亿 | -19.9% |
| Deferred Income Tax Expense (Benefit) | – | – | – | $1.19亿 | -$1.17亿 | +201.7% |
| Deferred State and Local Income Tax Expense (Benefit) | – | – | – | $1900万 | -$5600万 | +133.9% |
| Deferred Tax Assets, Gross | $8.35亿2025-12-28 | $9.53亿 | -12.4% | $8.35亿 | $9.53亿 | -12.4% |
| Deferred Tax Assets, in Process Research and Development | $1.34亿2025-12-28 | $1.81亿 | -26.0% | $1.34亿 | $1.81亿 | -26.0% |
| Deferred Tax Assets, Investments | $02025-12-28 | $2300万 | -100.0% | $0 | $2300万 | -100.0% |
| Deferred Tax Assets, Net | $4.5亿2025-12-28 | $5.58亿 | -19.4% | $4.5亿 | $5.58亿 | -19.4% |
| Deferred Tax Assets, Net of Valuation Allowance | $5.85亿2025-12-28 | $6.75亿 | -13.3% | $5.85亿 | $6.75亿 | -13.3% |
| Deferred Tax Assets, Operating Loss Carryforwards | $1.25亿2025-12-28 | $1.89亿 | -33.9% | $1.25亿 | $1.89亿 | -33.9% |
| Deferred Tax Assets, Other | $6800万2025-12-28 | $6300万 | +7.9% | $6800万 | $6300万 | +7.9% |
| Deferred Tax Assets, Property, Plant and Equipment | $2200万2025-12-28 | $1700万 | +29.4% | $2200万 | $1700万 | +29.4% |
| Deferred Tax Assets, Tax Credit Carryforwards | $2.9亿2025-12-28 | $2.52亿 | +15.1% | $2.9亿 | $2.52亿 | +15.1% |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | $3100万2025-12-28 | $3400万 | -8.8% | $3100万 | $3400万 | -8.8% |
| Deferred Tax Assets, Tax Deferred Expense, Other | $3600万2025-12-28 | $4200万 | -14.3% | $3600万 | $4200万 | -14.3% |
| Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other | $3200万2025-12-28 | $4000万 | -20.0% | $3200万 | $4000万 | -20.0% |
| Deferred Tax Assets, Valuation Allowance | $2.5亿2025-12-28 | $2.78亿 | -10.1% | $2.5亿 | $2.78亿 | -10.1% |
来源:SEC companyfacts(每份10-Q / 10-K的XBRL)。现金流量表的季度数据由10-Q标记的年初至今累计数推算。分部拆分带有维度标记,在分部章节中单独展示。
数据来源
报表、分部营收、指标和预期均根据公司文件标准化。分部利润及全部披露项目:SEC EDGAR(XBRL)。 已读取的文件: 10-Q 2026-09-27, 10-Q 2026-06-28, 10-Q 2026-03-29, 10-K 2025-12-28, 10-Q 2025-09-28, 10-Q 2025-06-29, 10-Q 2025-03-30, 10-K 2024-12-29, 10-Q 2024-09-29
数据截至 2026-11-02